EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dopant‐Regulated Piezocatalysts Evoke Sonopiezoelectric and Enzymatic PANoptosis for Synergistic Cancer Therapy

Linhong Zhong iD, Xun Guo, Liming Deng, Xiaoting Wang, Hongye He, Nianhong Wu, Rui Tang, Liang Chen iD, Yu Chen iD, Pan Li iD

Advanced Science · 2025

DOI: 10.1002/advs.202500406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Linhong Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Ultrasound Department of the Second Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ultrasound Molecular Imaging, Ch…. Hauptthemen laut MEDLINE: Neoplasms, Ultrasonic Therapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institutional Animal Care and Use of Chongqing Medical University, National Natural Science Foundation of China, National Key Research and Development Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Piezocatalyst‐enabled sonopiezoelectric therapy offers noninvasive treatment with high spatiotemporal selectivity, yet existing piezocatalysts are limited by suboptimal efficacy, cancer cell resistance to oxidative stress, and biosafety concerns. Here, hafnia (HfO 2 ), one of the only few FDA‐approved inorganic nanomaterials for clinical trials, is identified as a promising piezocatalyst with high translational potential for sonopiezoelectric and enzymatic PANoptosis‐boosted nanocatalytic therapy. Specifically, engineered transition metal‐substituted HfO 2 nanocatalysts are synthesized to optimize piezoelectric and enzyme‐mimicking activities. Among these, Mn‐substituted HfO 2 with a 20% Mn ratio (HMO) demonstrates superior performance in sono‐triggered reactive oxygen species generation, attributed to its reduced bandgap and increased oxygen vacancies. HMO also exhibits multiple enzyme‐mimicking activities, including peroxidase (POD), catalase (CAT), and glutathione peroxidase (GPx), amplifying oxidative stress through tumor‐specific catalytic reactions. These dual catalytic effects enable the activation of cancer cell PANoptosis to elicit a robust antitumor immune response. Biological evaluations show significant tumor suppression and antitumor immune responses by HMO‐mediated nanocatalytic therapy. Unlike utilizing the radiosensitization ability of HfO 2 in the clinic, this work unveils the distinctive sonopiezoelectric effect and multienzymatic activities of HfO 2 ‐based nanocatalysts for biomedical applications, holding the potential to overcome the challenges of radiation damage associated with radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsUltrasonic TherapyAnimalsHumansMiceReactive Oxygen SpeciesCell Line, TumorOxidative StressCatalysis

Stichwörter der Autor:innen

PANoptosisenzymatic activityhafnium oxidenanocatalytic therapypiezoelectric biomaterials

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Ultrasound Department of the Second Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ultrasound Molecular Imaging, Chongqing, 400010, P. R. China.
  • The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, P. R. China.
  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
  • Shanghai Institute of Materdicine, Shanghai, 200051, P. R. China.

ORCID-Profile: Linhong Zhong, Liang Chen, Yu Chen, Pan Li

Förderung

  • Institutional Animal Care and Use of Chongqing Medical University
  • National Natural Science Foundation of China
  • National Key Research and Development Projects
  • Chenguang Program of the Shanghai Education Development Foundation and Shanghai Municipal Education Commission, Shanghai Science and Technology Program
  • Science and Technology Commission of Shanghai Municipality
  • Wenzhou Basic Scientific Research Project

Zitieren

APA

Zhong, L., Guo, X., Deng, L., Wang, X., He, H., Wu, N., Tang, R., Chen, L., Chen, Y., & Li, P. (2025). Dopant‐Regulated Piezocatalysts Evoke Sonopiezoelectric and Enzymatic PANoptosis for Synergistic Cancer Therapy. Advanced Science. https://doi.org/10.1002/advs.202500406

Vancouver

Zhong L, Guo X, Deng L, Wang X, He H, Wu N, et al. Dopant‐Regulated Piezocatalysts Evoke Sonopiezoelectric and Enzymatic PANoptosis for Synergistic Cancer Therapy. Advanced Science. 2025. doi:10.1002/advs.202500406

BibTeX
@article{Zhong2025,
  author = {Zhong, Linhong and Guo, Xun and Deng, Liming and Wang, Xiaoting and He, Hongye and Wu, Nianhong and Tang, Rui and Chen, Liang and Chen, Yu and Li, Pan},
  title = {Dopant‐Regulated Piezocatalysts Evoke Sonopiezoelectric and Enzymatic PANoptosis for Synergistic Cancer Therapy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202500406}
}
Kostenlos starten →